细胞分离技术市场－全球产业规模、份额、趋势、机会及预测（依产品、技术、应用、最终用途、地区及竞争格局划分），2021-2031年

全球细胞分离技术市场预计将从 2025 年的 159.5 亿美元成长到 2031 年的 270.6 亿美元，复合年增长率为 9.21%。

这些技术，包括用于从血液和组织等多种生物来源中提取和纯化特定细胞群的专用解决方案，在研究、诊断和治疗应用中发挥着至关重要的作用。该领域的成长主要得益于再生医学的快速发展以及对细胞疗法（尤其是在肿瘤学和免疫学领域）日益增长的需求。生物技术研发投入的不断增加进一步强化了这一趋势，因为这些投入需要精确的细胞分离以进行下游分析和生产。正如再生医学联盟所指出的，预计到2024年，美国和欧洲将对多达17种新型细胞和基因疗法做出监管决定，凸显了强大的研发管线，并将推动对分离工具的需求。

儘管取得了这些进展，但先进分离设备的高成本和技术复杂性仍然是市场面临的重大障碍。如何在不牺牲产量的前提下实现高纯度和高活性仍然是一个挑战，而自动化临床级系统所需的大量资金有效地阻碍了小规模实验室和新兴生物技术公司采用这些系统。这种经济壁垒限制了最尖端科技的普及，并可能阻碍市场更广泛的扩张。

市场驱动因素

细胞和基因治疗领域的快速发展是推动先进细胞分离技术广泛应用的主要动力。随着自体和异体疗法生产的扩大，分离高纯度免疫细胞（例如T细胞和NK细胞）对于确保治疗的安全性和有效性至关重要。活跃的临床研发管线直接导致了磁珠以微珠为基础系统和流式细胞技术平台采购量的增加，这些设备用于处理大量的生物材料。根据美国基因与细胞治疗学会（ASGCT）2024年4月发表的《基因、细胞与RNA疗法现况：2024年第一季季报告》，全球在开发平臺治疗方法3951种，凸显了该产业目前所需的庞大处理规模。

同时，慢性疾病（尤其是癌症）的日益流行，对用于基础研究和诊断的可靠细胞分离通讯协定提出了更高的要求。在肿瘤学研究中，循环性肿瘤细胞和特定淋巴细胞亚群的分离对于了解疾病进展和开发精准治疗方法至关重要，这推动了微流体技术和密度梯度离心技术在高度特异性样本处理中的应用。美国癌症协会在2024年1月发布的报告《2024年癌症事实与数据》中预测，美国将新增2,001,140例癌症病例，凸显了提高诊断通量的迫切需求。这项需求正得到业界的大力支持。根据欧洲製药工业协会联合会（EFPIA）2024年6月发布的报告《2024年製药业数据》，以研发为导向的生物製药行业预计将在2023年于欧洲投资500亿欧元用于研发，从而确保关键分离基础设施的持续资金筹措。

市场挑战

全球细胞分离技术市场受到高额资本投入和先进分离设备技术复杂性的显着限制。自动化临床级系统的高昂价格为资源有限的机构（例如小规模实验室和新兴生物技术公司）设置了很高的进入门槛。这些机构往往难以证明高效能平台的初始投入是合理的，这限制了它们达到竞争性研发所需的纯度和活力标准的能力。因此，这种经济上的排他性阻碍了行业标准解决方案的广泛应用，迫使小规模的企业依赖效率较低的手动方法。

早期企业的资金筹措环境日益恶化，进一步加剧了这种经济压力，直接导致资本设备预算缩减。根据生技创新组织（BIO）的数据显示，生技Start-Ups的资金筹措从2025年第一季的26亿美元骤降至第二季的仅9亿美元。可用资金的急剧下降迫使新兴企业推迟关键基础设施升级，甚至完全放弃先进设备。因此，关键成长领域的市场采用率放缓，有效限制了整个细胞分离产业的扩张。

市场趋势

一项重大的行业变革趋势正在推动对单细胞分离解决方案的需求，其驱动力源于基因组学和太空生物学中分析细胞异质性的关键需求。研究人员越来越重视能够温和分离单一细胞并维持其高活性的技术，以确保下游应用（例如单细胞RNA定序和多体学分析）的完整性。这种转变正将市场关注点从批量细胞分选转向能够无损处理脆弱样本（例如分散的组织和罕见的患者样本）的精准平台。 10x Genomics在2025年11月发布的2025年第三季财报中公布了1.49亿美元的营收，这印证了市场对高解析度工具的持续需求。这反映了该公司单细胞和空间分析架构的持续强劲应用，而该架构依赖高品质的上游工程细胞製备。

同时，市场正积极向全自动闭合迴路加工流程转型，以支持细胞和基因疗法的商业性规模生产。随着治疗方法从临床开发推进到上市核准，製造商正从人工开放式分离方法转向自动化平台，以确保符合良好生产规范 (GMP) 并最大限度地降低污染风险。这项转变的驱动力在于商业规模生产中对产品品质一致性和可重复性的需求，这与早期研究阶段的要求截然不同。监管审批的加速成功标誌着该行业的成熟。再生医学联盟在 2025 年 1 月发布的《2025 年产业趋势简报》中指出，2024 年新增细胞和基因疗法核准数量创下历史新高，达到 9 项，预示着该产业正向大规模、标准化的生产基础设施发生重大转变。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球细胞分离技术市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（消耗品、设备）
  • 透过技术（表面标誌物分离、梯度离心）
  • 依应用领域（肿瘤学研究、干细胞研究、神经科学研究、微生物学研究、免疫学研究等）
  • 依最终用户（生物技术/生物製药公司、细胞库、学术机构）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美细胞分离技术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲细胞分离技术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区细胞分离技术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲细胞分离技术市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美细胞分离技术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球细胞分离技术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Akadeum Life Sciences, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bristol-Myers Squibb Company
• Danaher Corporation
• GE HealthCare Technologies Inc.
• Merck & Co., Inc.
• STEMCELL Technologies Canada Inc.
• Terumo Corporation
• Thermo Fisher Scientific Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Cell Separation Technologies Market is projected to expand from USD 15.95 Billion in 2025 to USD 27.06 Billion by 2031, registering a compound annual growth rate of 9.21%. These technologies encompass specialized solutions designed to extract and purify distinct cell populations from heterogeneous biological sources, such as blood and tissue, serving critical roles in research, diagnostics, and therapeutic applications. The sector's momentum is primarily fueled by the burgeoning field of regenerative medicine and the escalating demand for cell-based therapies, especially within oncology and immunology. This trajectory is reinforced by growing investments in biotechnology research and development, which require precise cell isolation for downstream analysis and manufacturing. As noted by the Alliance for Regenerative Medicine, the industry anticipated up to 17 regulatory decisions for new cell and gene therapies in the United States and Europe during 2024, highlighting the robust pipeline stimulating the demand for separation tools.

Despite these advancements, the market encounters significant hurdles related to the high costs and technical intricacies of advanced separation instruments. Balancing high purity and viability without sacrificing yield remains a persistent difficulty, while the substantial capital required for automated, clinical-grade systems can effectively bar adoption by smaller research laboratories and emerging biotechnology companies. This financial barrier limits the accessibility of cutting-edge technology, potentially impeding the broader expansion of the market.

Market Driver

The rapid proliferation of the cell and gene therapy sector serves as a major catalyst for the uptake of sophisticated cell separation technologies. As manufacturers ramp up production for autologous and allogeneic therapies, achieving high-purity isolation of immune cells, such as T-cells and NK cells, is essential for ensuring therapeutic safety and efficacy. This intense activity in clinical pipelines leads directly to increased procurement of magnetic bead-based systems and flow cytometry platforms to handle the volume of biological starting materials. According to the American Society of Gene & Cell Therapy's April 2024 report, "Gene, Cell, & RNA Therapy Landscape: Q1 2024 Quarterly Report," the global development pipeline has reached 3,951 therapies, emphasizing the massive processing scale currently required by the industry.

Simultaneously, the rising prevalence of chronic diseases, especially cancer, demands robust cell separation protocols for both fundamental research and diagnostic purposes. Oncological studies depend heavily on isolating circulating tumor cells and specific lymphocyte subsets to elucidate disease progression and create precision treatments, driving the use of microfluidics and density gradient centrifugation for high-specificity sample processing. The American Cancer Society projected in January 2024, within "Cancer Facts & Figures 2024," that the United States would see 2,001,140 new cancer cases, signaling an urgent need for higher diagnostic throughput. This demand is supported by significant industry commitment; as per the European Federation of Pharmaceutical Industries and Associations' June 2024 report, "The Pharmaceutical Industry in Figures 2024," the research-based biopharmaceutical industry invested €50 billion in R&D across Europe in 2023, securing continuous funding for vital separation infrastructure.

Market Challenge

The Global Cell Separation Technologies Market is significantly constrained by the substantial capital investment and technical sophistication associated with advanced separation instruments. Automated, clinical-grade systems come with premium pricing that creates a high barrier to entry for resource-limited entities, such as smaller research laboratories and nascent biotechnology firms. These organizations often find it difficult to justify the upfront costs of high-performance platforms, which limits their ability to attain the purity and viability standards necessary for competitive research and development. Consequently, this financial exclusivity hinders the widespread adoption of industry-standard solutions, compelling smaller players to depend on less efficient manual methods.

This economic pressure is intensified by a tightening funding landscape for early-stage companies, which directly curtails budgets for capital equipment. According to the Biotechnology Innovation Organization, biotech startup funding plummeted from $2.6 billion in the first quarter of 2025 to just $900 million in the second quarter. This sharp reduction in available capital forces emerging firms to postpone critical infrastructure upgrades or forego advanced instrumentation entirely. As a consequence, the market suffers from slower penetration rates in key growth segments, effectively restricting the overall expansion of the cell separation industry.

Market Trends

A major trend transforming the industry is the escalating demand for single-cell isolation solutions, spurred by the critical requirement to analyze cellular heterogeneity within genomics and spatial biology. Researchers are increasingly prioritizing technologies capable of gently isolating individual cells with high viability to preserve the integrity of downstream applications such as single-cell RNA sequencing and multi-omic profiling. This shift redirects market focus from bulk population sorting toward precision platforms that can process fragile inputs, like dissociated tissue or rare patient samples, without causing stress. Underscoring this sustained demand for high-resolution tools, 10x Genomics reported revenue of $149.0 million in its November 2025 "Third Quarter 2025 Financial Results," reflecting the continued robust adoption of its single-cell and spatial architectures that depend on high-quality upstream cell preparation.

Concurrently, the market is aggressively shifting toward fully automated and closed-loop processing workflows to support the commercial scale-up of cell and gene therapies. As therapies advance from clinical development to market authorization, manufacturers are substituting manual, open-system isolation methods with automated platforms that ensure Good Manufacturing Practice (GMP) compliance and minimize contamination risks. This evolution is driven by the need for consistent, reproducible product quality at a commercial scale, differing significantly from early-stage research requirements. The maturation of the industry is highlighted by accelerating regulatory success; the Alliance for Regenerative Medicine noted in its January 2025 "2025 State of the Industry Briefing" that the sector achieved a record nine new cell and gene therapy approvals in 2024, signaling a crucial pivot toward high-volume, standardized manufacturing infrastructure.

Key Market Players

• Akadeum Life Sciences, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bristol-Myers Squibb Company
• Danaher Corporation
• GE HealthCare Technologies Inc.
• Merck & Co., Inc.
• STEMCELL Technologies Canada Inc.
• Terumo Corporation
• Thermo Fisher Scientific Inc.

Report Scope

In this report, the Global Cell Separation Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Separation Technologies Market, By Product

• Consumables
• Instruments

Cell Separation Technologies Market, By Technology

• Surface Markers Separation
• Gradient Centrifugation

Cell Separation Technologies Market, By Application

• Oncology Research
• Stem Cell Research
• Neuroscience Research
• Microbiology
• Immunology Research
• Others

Cell Separation Technologies Market, By End Use

• Biotechnology & Biopharmaceutical Companies
• Cell Banks
• Academic Institutes

Cell Separation Technologies Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Separation Technologies Market.

Available Customizations:

Global Cell Separation Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Separation Technologies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Instruments)
  • 5.2.2. By Technology (Surface Markers Separation, Gradient Centrifugation)
  • 5.2.3. By Application (Oncology Research, Stem Cell Research, Neuroscience Research, Microbiology, Immunology Research, Others)
  • 5.2.4. By End Use (Biotechnology & Biopharmaceutical Companies, Cell Banks, Academic Institutes)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Cell Separation Technologies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Separation Technologies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Cell Separation Technologies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Cell Separation Technologies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End Use

7. Europe Cell Separation Technologies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell Separation Technologies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End Use
  • 7.3.2. France Cell Separation Technologies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End Use
  • 7.3.3. United Kingdom Cell Separation Technologies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Cell Separation Technologies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Cell Separation Technologies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End Use

8. Asia Pacific Cell Separation Technologies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cell Separation Technologies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Cell Separation Technologies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan Cell Separation Technologies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Korea Cell Separation Technologies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Cell Separation Technologies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End Use

9. Middle East & Africa Cell Separation Technologies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cell Separation Technologies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End Use
  • 9.3.2. UAE Cell Separation Technologies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End Use
  • 9.3.3. South Africa Cell Separation Technologies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End Use

10. South America Cell Separation Technologies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cell Separation Technologies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End Use
  • 10.3.2. Colombia Cell Separation Technologies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End Use
  • 10.3.3. Argentina Cell Separation Technologies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cell Separation Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Akadeum Life Sciences, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Bio-Rad Laboratories, Inc.
• 15.4. Bristol-Myers Squibb Company
• 15.5. Danaher Corporation
• 15.6. GE HealthCare Technologies Inc.
• 15.7. Merck & Co., Inc.
• 15.8. STEMCELL Technologies Canada Inc.
• 15.9. Terumo Corporation
• 15.10. Thermo Fisher Scientific Inc.

16. Strategic Recommendations

17. About Us & Disclaimer